Skip to main content

Pregabalin

NDC 76282-572 · Exelan Pharmaceuticals Inc.

Generic namePREGABALIN
Dosage formCAPSULE
RouteORAL
Active ingredient(s)PREGABALIN
Strength150 mg/1
DEA scheduleCV
Marketing categoryANDA

Packages

76282-572-05 — 500 CAPSULE in 1 BOTTLE (76282-572-05)

76282-572-90 — 90 CAPSULE in 1 BOTTLE (76282-572-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

73190-055 — Pregabalin, 73190-056 — Pregabalin, 73190-057 — Pregabalin, 73190-058 — Pregabalin, 73190-059 — Pregabalin, 73190-060 — Pregabalin, 76282-568 — PREGABALIN, 76282-569 — PREGABALIN, 76282-570 — PREGABALIN, 76282-571 — PREGABALIN, 76282-573 — PREGABALIN, 76282-574 — PREGABALIN, 76282-575 — PREGABALIN, 76420-095 — PREGABALIN, 76420-096 — PREGABALIN, 76420-097 — PREGABALIN, 76420-098 — PREGABALIN, 76420-099 — PREGABALIN, 76420-100 — PREGABALIN, 76420-101 — PREGABALIN, +519 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels